Navan Ward, a lawyer in our firm’s Mass Torts Section, was recently appointed to the Plaintiffs’ Steering Committee (PSC) for the Biomet hip replacement defect Multi-District Litigation (MDL) which is situated in South Bend, Ind. The PSC is responsible for the management of all of the cases involved in the Biomet MDL. Biomet is one of the latest corporations that has come under fire for its manufacture of its M2a-Magnum and M2a 38-diameter metal-on-metal hip replacement implant devices. Both of these devices are still sold and implanted into an unsuspecting patient population in the United States.
Hip replacement devices are implanted in patients with conditions such as osteoarthritis, rheumatoid arthritis, avascular necrosis, functional deformity or femoral fracture. Once implanted, these devices are expected to last for an average of about fifteen (15) or more years before requiring replacement. However, these devices fail at rates higher than other hip replacement devices necessitating early removal.
Biomet marketed the M2a as having numerous advantages over other hip replacement systems. It described the M2a as having “set the standard for performance and design in hip systems” and as “an ultra-high performance metal-on-metal articulation.” Biomet further advertised the M2a as a superior device because the hip system was subject to low wear, excellent stability, good range of motion and superior joint mechanic restoration.
Unfortunately, metal-on-metal implants have been found to cause a multitude of problems including, but not limited to, metallic debris causing the destruction and degradation of surrounding tissue and bone, pseudotumors, metal blood poisoning. These metal-on-metal implants are worse than their polyethylene predecessors because of the damage caused to the body from the metal debris. These Biomet hip replacement systems have a higher propensity to produce high levels of metal ions, particularly cobalt, in the bloodstream. High levels of cobalt can lead to headaches, blindness, peripheral neuropathy, and convulsions, among other illnesses. There is no medical solution to elevated metal ions.
Navan was also selected to the Plaintiffs’ Steering Committee for the DePuy Hip Implant Recall MDL, as well as to the PSC for the Pinnacle hip replacement MDL. Additionally, he serves as Co-Chair to the DePuy Metal-on-Metal Hip Implant Litigation Group for the American Association for Justice (AAJ). Lawyers in our firm, led by Navan Ward, represent clients with the following hip and knee replacement implants:
• DePuy ASR and Pinnacle;
• Biomet M2a-Magnum and M2a-38;
• Zimmer Durom cup;
• Stryker Rejuvenate and ABG II;
• Wright Conserve, Dynasty, Lineage, and Profemur (femur fractures);
• Smith and Nephew R3 liner hips; and,
• Zimmer NexGen knee replacements.
If you have any questions about anything relating to either the hip or knee replacement litigation, contact Navan Ward at 800-898-2034 or by email at Navan.Ward@beasleyallen.com.
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.